| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative + 1995-1999) |
0.38 |
8 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay)  |
163 |
| Staphylococci (coagulase-negative + 1995-1999) |
0.38 |
8 |
? － ? |
Ofloxacin (Floxin) |
163 |
| Staphylococci (coagulase-negative + 2000-2004) |
0.12 |
32 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
163 |
| Staphylococci (coagulase-negative + 2000-2004) |
0.19 |
32 |
? － ? |
Gatifloxacin (Tequin) |
163 |
| Staphylococci (coagulase-negative + 2000-2004) |
0.5 |
0.5 |
? － ? |
Ofloxacin (Floxin) |
163 |
| Staphylococci (coagulase-negative + 2000-2004) |
0.5 |
32 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
163 |
| Staphylococci (coagulase-negative + 284) |
2 |
4 |
0.12 － >4 |
Gatifloxacin (Tequin) |
123 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
0.21 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
901 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
0.5 － ? |
Tigecycline (GAR-936, Tigacyl) |
901 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
1.17 － ? |
Daptomycin (Cubicin) |
901 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
1.3 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
901 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
1.67 － ? |
Vancomycin (Vancocyn, Lyphocin) |
901 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
3.33 － ? |
Teicoplanin (Targocid) |
901 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
5.4 － ? |
Gentamicin (Gentamycin, Garamycin) |
901 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
6.3 － ? |
Quinupristin/Dalfopristin (Synercid) |
901 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
9.3 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
901 |
| Staphylococci (coagulase-negative + beef isolate + Korea) |
- |
- |
>128 － ? |
Mupirocin (Bactroban) |
901 |
| Staphylococci (coagulase-negative + erythromycin-resistant) |
>16 |
>16 |
? － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
496 |
| Staphylococci (coagulase-negative + erythromycin-susceptible) |
0.06 |
0.06 |
? － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
496 |
| Staphylococci (coagulase-negative + ESBL) |
0.03 |
0.12 |
? － ? |
Clinafloxacin (PD 127391) |
307 |
| Staphylococci (coagulase-negative + ESBL) |
0.25 |
4 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
307 |
| Staphylococci (coagulase-negative + methicillin-resistant + non-Staphylococcus epidermidis) |
1 |
1 |
1 － 2 |
Eperezolid (PNU-100592) |
33 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.015 |
0.03 |
≤0.008 － 0.03 |
AC98-6446 |
175 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.03 |
0.06 |
≤0.015 － 0.25 |
Dalbavancin |
72 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.06 |
0.5 |
? － ? |
Clinafloxacin (PD 127391) |
307 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.12 |
4 |
0.03 － 8 |
Garenoxacin (T-3811, BMS-284756) |
102 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>0.12 |
>8 |
0.06 － >8 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.12 |
8 |
0.06 － 16 |
Sparfloxacin (AT-4140, Zagam) |
117 |